Table 3.
N | Before EPO and High Iron Supplementation | Last Measurement Before Discharge | Mean Change (95% CI) | P-value | |
---|---|---|---|---|---|
Hematological Indices: | |||||
Hemoglobin (gm/dL) | 116 | 14.1 ± 0.2 | 11.5 ± 0.1 | −2.6 (−3, −2.2) | <0.001 |
Hematocrit (%) | 116 | 42.2 ± 0.5 | 34.9 ± 0.4 | −7.2 (−8.4, −6) | <0.001 |
MCV (fL) | 116 | 113.6 ± 0.8 | 86.8 ± 0.7 | −26.9 (−28.6, - | <0.001 |
Red Cell Width (RDW | 116 | 16.4 ± 0.2 | 18.9 ± 0.3 | 2.4 (1.8, 3.1) | <0.001 |
Platelet Count (10^9/L) | 110 | 208.1 ± 6.3 | 318.9 ± 9.3 | 112.7 (92.7, | <0.001 |
Iron Indices: | |||||
Serum Iron (mcg/dL) | 116 | 58.1 ± 2.7 | 95.3 ± 3 | 37.2 (28.8, 45.5) | <0.001 |
Serum Ferritin (ng/mL) | 116 | 283.8 ± 15 | 96.8 ± 10.2 | −187 (−221.8, - | <0.001 |
TIBC (mcg/dL) | 116 | 285.2 ± 4.8 | 326.1 ± 6.1 | 41 (25, 56.9) | <0.001 |
Transferrin Saturation | 116 | 20.7 ± 1 | 29.9 ± 0.9 | 9.1 (6.5, 11.8) | <0.001 |
Transferrin (mg/dL) | 116 | 190.8 ± 3.2 | 218.8 ± 4.1 | 28 (17.2, 38.7) | <0.001 |
Mean ± SE